Literature DB >> 27413506

Hydrophilic Acrylic Intraocular Lens Opacification after Descemet Stripping Automated Endothelial Keratoplasty.

Amir Norouzpour1, Siamak Zarei-Ghanavati1.   

Abstract

PURPOSE: To report hydrophilic acylic intraocular lens (IOL) opacification after Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) in an eye with multiple prior intraocular surgeries and iatrogenic aniridia. CASE REPORT: A 34-year-old woman with history of penetrating keratoplasty (PKP) for advanced keratoconus and subsequent Urrets-Zavalia Syndrome (UZS) underwent phacoemulsification and hydrophilic acrylic IOL implantation for her cataract. In order to control post-PKP glaucoma, multiple glaucoma surgeries including two glaucoma drainage implants were performed. As the original corneal graft failed, the patient subsequently underwent re-PKP. Four years later, she underwent DSAEK for treatment of the second graft failure. Ten months after DSAEK, a double semi-circular pattern of IOL opacification was observed on the anterior surface of the IOL. The patient did not report any complaints and we decided not to exchange the IOL.
CONCLUSION: In an eye with UZS and iatrogenic aniridia, IOL opacification may result from direct contact between the IOL surface and exogenous air. Aniridia can be a risk factor for development of IOL opacification after DSAEK. Further studies are required to confirm this hypothesis.

Entities:  

Keywords:  Descemet Stripping Automated Endothelial Keratoplasty; Hydrophilic Intraocular lens; Intracameral Air; Opacification

Year:  2016        PMID: 27413506      PMCID: PMC4926573          DOI: 10.4103/2008-322X.158897

Source DB:  PubMed          Journal:  J Ophthalmic Vis Res        ISSN: 2008-322X


INTRODUCTION

Descemet stripping endothelial keratoplasty/Descemet stripping automated endothelial keratoplasty (DSEK/DSAEK) is currently considered as the procedure of choice in eyes with corneal endothelial dysfunction.[1] Although these procedures offer certain advantages over conventional penetrating keratoplasty (PKP),[234] experience with these procedures is not as extensive and few reports regarding their complications have been published.[3] Patients undergoing DSEK/DSAEK are frequently pseudophakic because the crystalline lens has usually been removed before or during DSEK/DSAEK.[5] Therefore, few cases with intraocular lens (IOL) complications after DSEK/DSAEK have been reported.[6789] In this report, we describe a patient with IOL opacification 10 months after DSAEK, with a history of multiple intraocular surgeries and iatrogenic aniridia as a result of Urrets-Zavalia Syndrome (UZS).

CASE REPORT

A healthy 34-year-old woman with a history of bilateral keratoconus underwent PKP in her left eye because of advanced ectasia in 1999 followed by UZS after surgery. The patient was treated with topical β–blocker and carbonic anhydrase inhibitor drops. Seven years later in 2006, trabeculectomy was performed in the left eye to control post-PKP glaucoma. In 2007, she underwent uneventful phacoemulsification with foldable hydrophilic acrylic IOL implantation (Akreos Adapt Advanced Optics [AO], Bausch and Lomb Inc., Berlin, Germany). Intraocular pressure (IOP) of the same eye became uncontrolled again, requiring Ahmed Glaucoma Valve (AGV) implantation twice within a 9-month interval after cataract surgery. The original corneal graft was failed in 2009, requiring re-PKP, which also failed in 2013. Subsequently, she was subjected to an uncomplicated DSAEK in the left eye. In order to completely appose the lenticule to the recipient's stroma and control postoperative hypotony secondary to the AGV (considering no risk of pupillary block in an eye with aniridia), the anterior chamber was filled with air at the end of DSAEK. The patient was treated with topical betamethasone eye drops 4 times per day for 3 months which was tapered off monthly and maintained at a dose of once daily. No sign of postoperative anterior chamber inflammation was noted. Best corrected distance visual acuity (BCDVA) of the left eye was 20/600 (1.47 LogMAR) before DSAEK, which improved to 20/100 (0.699 LogMAR) and 20/50 (0.398 LogMAR) at months 2 and 4 after DSAEK, respectively. Ten months following DSAEK, the corneal graft was clear. No sign of anterior chamber inflammation was noted, and IOP was controlled. BCDVA remained at 20/50 (0.398 LogMAR) and the patient was asymptomatic. However, slit lamp examination revealed a double semi-circular pattern of white opacification on the anterior surface of the IOL. The semi-circles consisted of white granular opacities on the lens surface. The semi-circles were attached superiorly and there was a tapering tail inferiorly [Figure 1].
Figure 1

A double semi-circular pattern of IOL opacification is seen superiorly, on the anterior surface of the intraocular lens adjacent to the Ahmed glaucoma valve tube.

A double semi-circular pattern of IOL opacification is seen superiorly, on the anterior surface of the intraocular lens adjacent to the Ahmed glaucoma valve tube.

DISCUSSION

Distinctive patterns of calcification on various hydrophilic acrylic IOLs following procedures using intracameral injections of air or gas have been reported.[678910] Calcification is localized to the anterior surface/subsurface of the IOL, within the pupillary area, and occurs in a circular pattern.[910] It remains unclear whether the localized IOL calcification results from direct contact between the IOL surface and exogenous gas (i.e., gas/air), a metabolic change in the anterior chamber due to the presence of exogenous gas, or an exacerbated inflammatory reaction after multiple surgical procedures. In this report, we describe a case with IOL opacification 10 months after DSAEK in an eye with history of multiple intraocular surgeries including PKP and AGV implantation. Our patient had a similar pattern of opacification as similar cases reported in the literature; the IOL opacification was limited to the anterior surface of the IOL. Furthermore, our patient experienced a similar history of intracameral air injection. IOL opacification, in our case, was observed after the last surgical procedure, namely DSAEK, and not after other surgeries such as PKP or glaucoma surgery. One factor which differentiates DSAEK from PKP is leaving an air bubble in the anterior chamber after the former procedure and this intracameral air may play have played a key role in the development of IOL opacification. Moreover, UZS developed in our patient and the subsequently iatrogenic aniridia provided a large contact area between the IOL and the air bubble in the anterior chamber. IOL opacification had a distinctive, double semi-circular pattern superiorly. The opacification was adjacent to the tip of the AGV tube. As air stays superiorly and exits the anterior chamber through the AGV tube, the superior part of the IOL adjacent to the tip of the AGV tube can get into direct contact with the air bubble for a long time. Interestingly, the white semi-circles were incomplete inferiorly which might have resulted from an air-fluid interface at the lower border of the air bubble. These observations support the hypothesis that IOL opacification may occur due to direct contact between the IOL surface and exogenous air. The presence of intraocular air in the anterior chamber can lead to dehydration of the anterior surface of hydrophilic IOL. This structural change may induce proteins and/or other soluble materials in the aqueous to precipitate onto the anterior substance of the IOL and then act as a nidus for dystrophic calcification. In case of multiple ocular surgeries, the blood-ocular barrier breakdown could promote the opacification by increasing calcium and protein levels in the aqueous humor. However, further experimental studies are warranted to clarify the mechanism of IOL calcification and confirm the possible role of intraocular air and blood-ocular barrier breakdown. In summary, IOL opacification after DSAEK in an eye with multiple prior ocular surgeries and aniridia due to UZS may occur due to direct contact between the IOL surface and exogenous air. Regardless of the mechanism(s) underlying IOL opacification after intracameral air injection, it may be wise to avoid the use of hydrophilic acrylic IOLs when procedures with intracameral injection of air/gas are anticipated, particularly in aniridic eyes.

Financial Support and Sponsorship

Nil.

Conflicts of Interest

There are no conflicts of interest.
  10 in total

1.  Intraocular lens opacifications in Descemet stripping endothelial keratoplasty patients.

Authors:  Eliza Patryn; Ivanka J E van der Meulen; Ruth Lapid-Gortzak; Maarten Mourits; Carla P Nieuwendaal
Journal:  Cornea       Date:  2012-10       Impact factor: 2.651

2.  Localized calcification of hydrophilic acrylic intraocular lenses in association with intracameral injection of gas.

Authors:  Liliana Werner; Garth Wilbanks; Andrew Ollerton; Jennifer Michelson
Journal:  J Cataract Refract Surg       Date:  2012-02-10       Impact factor: 3.351

3.  Sequential Descemet's membrane detachments and intraocular lens haze secondary to SF6 or C3F8.

Authors:  M U Saeed; A J Singh; A J Morrell
Journal:  Eur J Ophthalmol       Date:  2006 Sep-Oct       Impact factor: 2.597

Review 4.  Descemet's stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology.

Authors:  W Barry Lee; Deborah S Jacobs; David C Musch; Stephen C Kaufman; William J Reinhart; Roni M Shtein
Journal:  Ophthalmology       Date:  2009-07-30       Impact factor: 12.079

5.  Calcification of a hydrophilic acrylic intraocular lens after Descemet-stripping endothelial keratoplasty: case report and laboratory analyses.

Authors:  Melissa A Fellman; Liliana Werner; Erica T Liu; Shannon Stallings; Anne M Floyd; Ivanka J E van der Meulen; Ruth Lapid-Gortzak; Carla P Nieuwendaal
Journal:  J Cataract Refract Surg       Date:  2013-03-28       Impact factor: 3.351

6.  Calcification in hydrophilic intraocular lenses associated with injection of intraocular gas.

Authors:  Anish Dhital; David J Spalton; Saurabh Goyal; Liliana Werner
Journal:  Am J Ophthalmol       Date:  2012-02-10       Impact factor: 5.258

7.  Retrospective contralateral study comparing descemet stripping automated endothelial keratoplasty with penetrating keratoplasty.

Authors:  Irit Bahar; Igor Kaiserman; Eliya Levinger; Wiwan Sansanayudh; Allan R Slomovic; David S Rootman
Journal:  Cornea       Date:  2009-06       Impact factor: 2.651

Review 8.  Descemet's stripping endothelial keratoplasty.

Authors:  Marianne O Price; Francis W Price
Journal:  Curr Opin Ophthalmol       Date:  2007-07       Impact factor: 3.761

9.  Endothelial keratoplasty for Fuchs' dystrophy with cataract: complications and clinical results with the new triple procedure.

Authors:  Mark A Terry; Neda Shamie; Edwin S Chen; Paul M Phillips; Anand K Shah; Karen L Hoar; Daniel J Friend
Journal:  Ophthalmology       Date:  2009-02-08       Impact factor: 12.079

10.  Descemet's stripping automated endothelial keratoplasty outcomes compared with penetrating keratoplasty from the Cornea Donor Study.

Authors:  Marianne O Price; Mark Gorovoy; Beth A Benetz; Francis W Price; Harry J Menegay; Sara M Debanne; Jonathan H Lass
Journal:  Ophthalmology       Date:  2010-01-19       Impact factor: 12.079

  10 in total
  3 in total

1.  Hydrophilic intraocular lens opacification after posterior lamellar keratoplasty - a material analysis with special reference to optical quality assessment.

Authors:  Bert C Giers; Tamer Tandogan; Gerd U Auffarth; Chul Y Choi; Florian N Auerbach; Saadettin Sel; Christian Mayer; Ramin Khoramnia
Journal:  BMC Ophthalmol       Date:  2017-08-22       Impact factor: 2.209

2.  Intraocular lens opacification after Descemet's stripping automated endothelial keratoplasty.

Authors:  Meng-Sheng Lee; I-Lun Tsai; Ching-Yao Tsai; Li-Lin Kuo; Shiow-Wen Liou; Lin-Chung Woung
Journal:  Taiwan J Ophthalmol       Date:  2017 Jul-Sep

3.  Inflammatory Precipitates in an Air Bubble in the Aqueous Humor.

Authors:  Saeed Shokoohi-Rad; Ghodsieh Zamani; Mohammad-Reza Doosti
Journal:  J Ophthalmic Vis Res       Date:  2017 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.